• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
  • Subscribe
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services
Latest ASX News

dorsaVi Share Price up 500% on Clinching New Deal (ASX:DVL)

Like 0

By Ryan Clarkson-Ledward, Thursday, 02 July 2020

Wearable technology can often feel like a fad. dorsaVi Ltd [ASX:DVL] has certainly lent credence to this line of thinking today. The share price in this tech small-cap are trading 515% higher at time of writing.

Wearable technology can often feel like a fad.

A market that is perhaps exemplified by the incredible rise and fall of Fitbit.

But, despite the shortcomings, wearable tech is still around. In fact, one could argue that it’s even making a comeback…

dorsaVi Ltd [ASX:DVL] has certainly lent credence to this line of thinking today. The share price in this tech small-cap are trading 515% higher at time of writing.

That in itself is a remarkable gain — but a far cry from the 1,592% peak recorded in earlier trading.

Suffice to say, day traders have had a field day with this stock.

Big deal with a big partner

The cause of this overnight success was a newly announced deal. One that will see dorsaVi partner up with insurance giant QBE.

With an initial $250,000 budget, QBE will offer their customers access to dorsaVi’s products. Devices that measure, track, and provide data on a company’s workforce.

With this information, companies can then see what exactly is going on. Paving the way for better practices to improve both safety and efficiency.

Though it is the former which QBE has far more interest in. No doubt looking to reduce the number of workplace incidents and subsequent claims. As their General Manager of People Risk notes:

‘Over the past two years we’ve been increasingly looking at ways we can reduce the risk of injury for workers. New technologies offer great promise for taking a proactive role in making workplaces safer and we’re excited to be working with dorsaVi’s technology to achieve this.’

For dorsaVi it also gives them a chance to show off their wares. Because if this initial 12-month deal is a success, more offers are bound to come knocking. Be it from QBE or elsewhere.

Converting on momentum

The challenge for dorsaVi now is to keep the ball rolling.

Landing this deal is huge, but they must build upon it. Finding further ways to convert this newfound limelight into a bottom-line win.

It’s a position that few small-caps ever reach, let alone capitalise upon. And for that reason, dorsaVi can’t afford to squander this chance.

This could be the start of something much bigger. And clearly shareholders are aware of that judging from the ravenous trading today.

If you missed the boat though, well, don’t feel too bad. There are still plenty of other promising small-caps to choose from right now.

In fact, we’ve got four that believe could be major, future winners. Check them out in our latest report, right here.

Regards,

Ryan Clarkson-Ledward,
For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Ryan Clarkson-Ledward

Ryan’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • If You’re Confused, So Is Everyone Else
    By Charlie Ormond

    The lack of a clear narrative for this market recovery suggests underlying confusion. So what can be done?

  • Another obstacle to the Epstein client list is falling
    By Brian Chu

    Progress in bringing justice on the Epstein saga has been slow. Yet, the latest takedown of a high-profile Democrat member might offer clues that the next steps of the process are underway.

  • Advanced Gamblenomics: A brief guide to why the ASX 200 sucks
    By Lachlann Tierney

    The historical performance of the S&P500 vs the ASX 200 reveals a big opportunity for Aussie investors. And it starts with what Lachlann Tierney calls “gamblenomics”.

Primary Sidebar

Latest Articles

  • If You’re Confused, So Is Everyone Else
  • Another obstacle to the Epstein client list is falling
  • Advanced Gamblenomics: A brief guide to why the ASX 200 sucks
  • We Made 110% on Oil. Here’s Why We Just Sold.
  • Iran War Winners #2 and #3: Copper and Nickel

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988